Concepedia

Larissa Atangan

LA

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

2004

Affiliations

Amgen (United States)(Current)

University of Birmingham

Allergan (United States)

Larissa Atangan is an author at Amgen (United States) specializing in pharmacology, medicine, and endocrinology.

Publications per year

2004–2025

11

Publications

11

Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity

Dirk Beher, John Y. Wu, Suzanne Cumine et al. · Chemical Biology & Drug Design · 2009 · 422 citations

, , +13

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie et al. · Science Translational Medicine · 2018 · 224 citations · Full text

, , +17

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan et al. · Nature Metabolism · 2024 · 188 citations · Full text

, , +17

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism

Elizabeth A. Killion, Michelle Chen, James R. Falsey et al. · Nature Communications · 2020 · 136 citations · Full text

, , +17

Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia

Wei Gu, Hai Yan, Katherine A. Winters et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 106 citations

, , +17

1–5 of 11